This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen A. McMahon ...

An oral therapy targeting toll-like receptors (TLR) 7 and 8 reduced disease activity in patients with cutaneous lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) with active lupus rash.

Yes, a lupus rash can be itchy, but it’s not always the case for everyone. Lupus, or systemic lupus erythematosus (SLE), is an autoimmune disease that can cause rashes and other skin issues. The most ...

That’s what the autoimmune disease lupus does, 1 and when it strikes, it can cause significant symptoms, including extreme ...

Imagine your body attacking itself. That’s what happens with lupus, a chronic autoimmune disease affecting millions worldwide. Lupus Alert Day is a chance to shine a spotlight on this condition. It’s ...

Saphnelo, a human monoclonal antibody, is a type 1 interferon (INF) receptor antagonist that inhibits a key protein in the immune system called the IFNAR receptor. This protein acts like a transmitter ...